In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Intravitreal aflibercept 2 mg regimen is linked with long-term visual acuity improvements in macular edema following CRVO.

A monitoring protocol can detect intraocular inflammation early and enable favorable visual outcomes in patients being treated for AMD.

The needle-free injection system market is expected to register a CAGR of approx. 13% over the period of 2022-2028. Needle-free injection technology (NFIT) refers to a wide range of drug delivery ...

Sylentis, a wholly-owned subsidiary of Spanish drugmaker PharmaMar (MSE: PHM), announced top-line results from the SYL1801-II ...

The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of ...

This retrospective case series involved a review of medical records at a single tertiary care center. Charbel Issa and ...

Intravitreal injections with anti-VEGF biological treatments (anti-angiogenic therapies that target VEGF) are first-line therapy for treating and stabilizing exudative neovascular AMD (nAMD).

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

Shorter needles are safer to avoid going into the muscle. The International Scientific Advisory Board for the Third Injection Technique Workshop states that there is no medical reason to use a ...

The lens is gently moved medially to allow the needle to reach the injection site. Resistance felt during needle advancement indicates successful penetration of the retina into the subretinal stroma.